MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $3,775,695 | -4.4% | 16,345 | +0.3% | 0.00% | 0.0% |
Q1 2023 | $3,949,080 | +103932.7% | 16,301 | +24.6% | 0.00% | 0.0% |
Q4 2022 | $3,796 | -99.9% | 13,079 | -71.6% | 0.00% | 0.0% |
Q3 2022 | $2,989,000 | -75.3% | 45,995 | -72.8% | 0.00% | -75.0% |
Q2 2022 | $12,117,000 | -42.9% | 169,294 | -21.7% | 0.00% | -42.9% |
Q1 2022 | $21,214,000 | +23.7% | 216,197 | +6.9% | 0.01% | +40.0% |
Q4 2021 | $17,144,000 | +23.2% | 202,312 | +16.0% | 0.01% | +25.0% |
Q3 2021 | $13,917,000 | -15.5% | 174,412 | +3.1% | 0.00% | -20.0% |
Q2 2021 | $16,479,000 | -18.3% | 169,172 | -1.9% | 0.01% | -28.6% |
Q1 2021 | $20,178,000 | -3.9% | 172,511 | -8.6% | 0.01% | -12.5% |
Q4 2020 | $20,992,000 | -11.5% | 188,830 | -5.5% | 0.01% | -20.0% |
Q3 2020 | $23,718,000 | +5.3% | 199,764 | +0.4% | 0.01% | 0.0% |
Q2 2020 | $22,531,000 | +70.7% | 199,020 | +0.7% | 0.01% | +42.9% |
Q1 2020 | $13,199,000 | -21.9% | 197,678 | +6.5% | 0.01% | +16.7% |
Q4 2019 | $16,904,000 | +70.0% | 185,544 | +60.9% | 0.01% | +50.0% |
Q3 2019 | $9,943,000 | +6.4% | 115,322 | +29.3% | 0.00% | 0.0% |
Q2 2019 | $9,346,000 | +331.9% | 89,176 | +416.4% | 0.00% | +300.0% |
Q1 2019 | $2,164,000 | +151.0% | 17,270 | +125.4% | 0.00% | – |
Q4 2018 | $862,000 | -64.4% | 7,662 | -32.2% | 0.00% | -100.0% |
Q3 2018 | $2,420,000 | +80.6% | 11,305 | +135.9% | 0.00% | 0.0% |
Q2 2018 | $1,340,000 | – | 4,793 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |